SuraClan » some content which

Free News Articles Home Business Drugs and Pharmaceuticals Medical Epeius Biotechnologies Awarded Federal Grant Advancing Tumor-Targeted Cancer Therapy Epeius Biotechnologies Awarded Federal Grant Advancing Tumor-Targeted Cancer Therapy Author: Epeius Biotechnologies Corporation
Dateline: San Marino https://www.scarpescontatenike.it/ , California (SAN MARINO, Calif.) | Mon, 08 Nov 2010

freeNewsArticles Story Summary: “Epeius Biotechnologies Corporation, a leader in the emerging field of targeted genetic medicine, announced today the receipt of additional financial support for the company's lead oncology product, Rexin-G Ingrosso Scarpe Online , from the U.S. Departments of Treasury, Health and Human Services (HHS), and the National Institutes of Health (NIH) in the form of a prestigious competitive grant.”

A R T I C L E:

Epeius Biotechnologies Corporation, a leader in the emerging field of targeted genetic medicine, announced today the receipt of additional financial support for the company's lead oncology product, Rexin-G® Scarpe Nike Online , from the U.S. Departments of Treasury, Health and Human Services (HHS), and the National Institutes of Health (NIH) in the form of a prestigious competitive grant.

This latest support for the clinical advancement of Rexin-G comes from the Qualifying Therapeutic Discovery Project (QTDP) program, created as a component of the Patient Protection and Affordable Care Act of 2010 to support projects that are determined by the HSS to have significant potential (i) to develop innovative new treatments to address major unmet medical needs, (ii) to reduce long-term health care costs, (iii) to represent significant medical progress toward an eventual treatmentcure for cancer Scarpe Nike In Offerta , (iv) to advance U.S. competitiveness in the fields of life science and medical technologies, and (v) to create andor sustain well-paying jobs in the United States.

This meritorious tranche of U.S. Government support for Rexin-G, the world's first and, so far, only targeted injectable genetic medicine for cancer that has been validated in clinical trials, represents the latest formal declaration of the potential importance Ingrosso Scarpe Nike , competitiveness, and overall merit of the platform of highly-advanced molecular biotechnologies and nanotechnologies embodied in this targeted injectable anticancer agent.

"We are very pleased with this formal recognition and support of our medical mission, for it represents a continuing commitment to develop the high-value products and intellectual properties of this company for the benefit of all," said Lina Kabayan, Epeius CFO who spearheaded this latest grant submission.

From the first National Science Foundation (NSF) and NIH grants awarded to the founders of Epeius Biotechnologies, to the American Heart Association (AHA) which provided funding to support the cardiovascular targeting technologies Scarpe Nike Italia , to the Office of Orphan Products Development (OOPD) which provided funding for the first clinical trials in the U.S., and which ultimately granted Orphan Drug Status to Rexin-G for three separate clinical indications (pancreatic cancer, soft tissue sarcoma, and osteosarcoma), to the U.S. FDA which granted Fast Track Status to Rexin-G for chemotherapy-resistant pancreatic cancer, the continuing federal support for these vital medical technologies is a testament that basic science and innovation in the service of medicine is still alive and well in America.

About Epeius Biotechnologies Corporation:

Epeius Biotechnologies Corporation is a privately held biopharmaceutical company that is bringing the latest advancements in genetic medicine to the cancer patient with the development and commercialization of its leading oncology products and its tumor-targeted delivery systems. Rexin-G® is currently approved for the treatment of all chemotherapy-resistant solid tumors by the Philippine FDA.

Learn more about our lead products andor our pipeline of proprietary biotechnologies at: http:www.epeiusbiotech . For recent papers Scarpe Nike Saldi , expert reviews, clinical reports in oncology and molecular therapy, see the "Publications" section.

###

Copyright © 2010 by Epeius Biotechnologies Corporation and Send2Press® Newswire, a service of Neotrope® - all rights reserved. Information believed accurate but not guaranteed. Sourced on: freeNewsArticles.

• Web Image (72dpi): https:www.send2pressmediaboom10-0907-epeiusbio_72dpi.jpg

• Story Title: Epeius Biotechnologies Awarded Federal Grant Advancing Tumor-Targeted Cancer Therapy
• REFERENCE KEYWORDSTERMS: targeted genetic medicine, San Marino, California Scarpe Nike Scontate , medicine for cancer, Drugs and Pharmaceuticals, Medical, Business, SAN MARINO, Calif..

IMPORTANT NOTICE: some content which is considered "old" or "archival" may reference an event which has already occurred; some content possibly considered "advertorial" may also reference a promotion or time-limitedsensitive offering, and in all of these instances certain material may no longer be valid. For notably stale content, you should directly contact the companyperson mentioned in the text (Epeius Biotechnologies Corporation); this site cannot assist you with information about productsservices mentioned in the news article, nor handle any complaints or other issues related to any personcompany mentioned or promoted in the above text. Information believed accurate but not guaranteed as of original date of story [Mon, 08 Nov 2010 11:47:57 GMT].

USE THIS CONTENT FOR FREE: To use this content in your newspaper, broadcast outlet, news portal#9# blogezine or similar, free of cost, CLICK HERE to learn how. A home owners' insurance is the cover for the house against natural calamities. Cheap Jerseys Wholesale Jerseys Wholesale Hoodie Wholesale Jerseys China Free Shipping Wholesale NBA Hoodie Wholesale T-Shirts Wholesale NHL T-Shirts Wholesale Football Hoodie Wholesale MLB Hats Cheap Nike NBA Hats